Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers A > Headlines for ArQule Inc. > News item |
Millenco sells off shares of ArQule
By Lisa Kerner
Charlotte, N.C., March 12 - Investors led by Millenco, LLC sold 3.25 million, or all but 100, of its shares of ArQule, Inc. common stock on Feb. 21 and March 10 priced from $3.90 to $5.11.
The transactions were reported in a schedule 13D filing with the Securities and Exchange Commission.
In August 2007, Millenco and its affiliates reported a 6.9% stake in ArQule.
Based in Woburn, Mass., ArQule is a biotechnology company focused on cancer therapeutics.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.